Cargando…

Yeast Models and Molecular Mechanisms of Neurodegenerative Diseases

Detalles Bibliográficos
Autores principales:	Kaminska, Joanna, Zoladek, Teresa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395755/ https://www.ncbi.nlm.nih.gov/pubmed/34445483 http://dx.doi.org/10.3390/ijms22168775

Ejemplares similares

Yeast Models and Molecular Mechanisms of Neurodegenerative Diseases 2.0
por: Kaminska, Joanna, et al.
Publicado: (2022)

Yeast as a Model to Find New Drugs and Drug Targets for VPS13-Dependent Neurodegenerative Diseases
por: Kaminska, Joanna, et al.
Publicado: (2022)

Targeting Copper Homeostasis Improves Functioning of vps13Δ Yeast Mutant Cells, a Model of VPS13-Related Diseases
por: Soczewka, Piotr, et al.
Publicado: (2021)

Flavonoids as Potential Drugs for VPS13-Dependent Rare Neurodegenerative Diseases
por: Soczewka, Piotr, et al.
Publicado: (2020)

The GTPase Arf1 Is a Determinant of Yeast Vps13 Localization to the Golgi Apparatus
por: Kolakowski, Damian, et al.
Publicado: (2021)

Neurodegenerative Diseases: Molecular Mechanisms and Therapies
por: Zhou, Zhi Dong, et al.
Publicado: (2023)

Yeast-model-based study identified myosin- and calcium-dependent calmodulin signalling as a potential target for drug intervention in chorea-acanthocytosis
por: Soczewka, Piotr, et al.
Publicado: (2019)

Amino acid substitution equivalent to human chorea-acanthocytosis I2771R in yeast Vps13 protein affects its binding to phosphatidylinositol 3-phosphate
por: Rzepnikowska, Weronika, et al.
Publicado: (2017)

Neurodegenerative disease: models, mechanisms, and a new hope
por: Gitler, Aaron D., et al.
Publicado: (2017)

Neurodegenerative Diseases: Mechanisms and Therapies
por: Smith, Mark A., et al.
Publicado: (2006)

New Insights into Molecular Mechanisms Underlying Neurodegenerative Disorders
por: Villa, Chiara, et al.
Publicado: (2022)

Imaging Neurodegenerative Diseases: Mechanisms and Interventions
por: Bai, Lijun, et al.
Publicado: (2014)

Neurodegenerative Diseases: From Molecular Basis to Therapy
por: Agnello, Luisa, et al.
Publicado: (2022)

The Molecular Basis for the Environmental Promotion of Neurodegenerative Disease
por: Bondy, Stephen
Publicado: (2023)

Oxidative Stress and Mitochondrial Damage in Neurodegenerative Diseases: From Molecular Mechanisms to Targeted Therapies
por: Cenini, Giovanna, et al.
Publicado: (2020)

Partial Inhibition of Calcineurin Activity by Rcn2 as a Potential Remedy for Vps13 Deficiency
por: Wardaszka, Patrycja, et al.
Publicado: (2021)

The PERK-Dependent Molecular Mechanisms as a Novel Therapeutic Target for Neurodegenerative Diseases
por: Rozpędek-Kamińska, Wioletta, et al.
Publicado: (2020)

Cell Death and Neurodegenerative Diseases: Mechanisms and Cytoprotective Molecules
por: Vejux, Anne
Publicado: (2023)

Antioxidant Therapies for Neurodegenerative Diseases: Mechanisms, Current Trends, and Perspectives
por: Gelain, Daniel Pens, et al.
Publicado: (2012)

Mitochondria in neurodegenerative diseases
por: Lin, Fang, et al.
Publicado: (2019)

Biomarkers in Neurodegenerative Diseases
por: Ghosh, Arnab
Publicado: (2022)

Advances in Neurodegenerative Diseases
por: Siokas, Vasileios, et al.
Publicado: (2022)

Advances in Neurodegenerative Diseases
por: Van Schependom, Jeroen, et al.
Publicado: (2023)

Lipids in Neurodegenerative Diseases
por: Chiurchiù, Valerio
Publicado: (2023)

Biochemical Biomarkers and Neurodegenerative Diseases
por: Ciaccio, Marcello
Publicado: (2021)

Protein Misfolding and Neurodegenerative Diseases
por: Cardinale, Alessio, et al.
Publicado: (2014)

Pain Assessment in Neurodegenerative Diseases
por: de Tommaso, Marina, et al.
Publicado: (2016)

Multitarget Therapeutics for Neurodegenerative Diseases
por: Gabr, Moustafa T., et al.
Publicado: (2020)

Neuroplasticity in the Pathology of Neurodegenerative Diseases
por: Dorszewska, Jolanta, et al.
Publicado: (2020)

Oxidative Stress in Neurodegenerative Diseases
por: Domanskyi, Andrii, et al.
Publicado: (2022)

Protein Kinases and Neurodegenerative Diseases
por: Kawahata, Ichiro, et al.
Publicado: (2023)

Cell Death, Inflammation and Oxidative Stress in Neurodegenerative Diseases: Mechanisms and Cytoprotective Molecules
por: Vejux, Anne
Publicado: (2021)

Copper Status in Alzheimer's Disease and Other Neurodegenerative Disorders: Genetics, Mechanisms, Neurophysiology, and Therapies
por: Squitti, Rosanna, et al.
Publicado: (2011)

Traditional Medicine for Treatment of Neurodegenerative Diseases
por: Wu, Chun Fu, et al.
Publicado: (2014)

Oxidative Stress in Neurodegenerative Diseases and Ageing
por: Pereira, Marcos D., et al.
Publicado: (2012)

IDOL in metabolic, neurodegenerative and cardiovascular disease
por: van Loon, Nienke M., et al.
Publicado: (2018)

Overcoming gaps in the treatment of neurodegenerative disease
Publicado: (2020)

Marijuana's potential in neurodegenerative diseases: an editorial
por: Arachchige, Arosh S. Perera Molligoda
Publicado: (2023)

Prevention, Intervention and Care of Neurodegenerative Diseases
por: Bakirtzis, Christos, et al.
Publicado: (2023)

The WIPI Gene Family and Neurodegenerative Diseases: Insights From Yeast and Dictyostelium Models
por: Vincent, Olivier, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_142ng5jd2jv2o2k02krqlt7o2k